Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC
1. VTAK is acquiring PeriKard, enhancing its product portfolio. 2. The acquisition involves issuing restricted VTAK stock for 100% interest.
1. VTAK is acquiring PeriKard, enhancing its product portfolio. 2. The acquisition involves issuing restricted VTAK stock for 100% interest.
The acquisition could create value through expanded offerings, similar to past sector consolidations.
The acquisition is likely to significantly impact VTAK's future growth prospects.
Long-term growth expected from the addition of PeriKard's assets, similar to prior acquisitions boosting revenue.